[Type-2-diabetes and cancer risk]

Area of Science:

• Endocrinology and Oncology
• Metabolic Disorders and Cancer Etiology

Background:

• Type-2 diabetes (T2D) is a significant risk factor for developing numerous types of cancer.
• Cancer is a primary cause of mortality among individuals diagnosed with T2D.
• The co-occurrence of T2D with lifestyle factors (smoking, obesity, poor diet) and infections exacerbates cancer risk.

Purpose of the Study:

• To elucidate the causal associations between Type-2 diabetes and a wide spectrum of malignancies.
• To highlight the increased cancer burden and earlier onset in T2D patients, particularly when combined with other risk factors.
• To advocate for enhanced cancer screening participation among the T2D population.

Main Methods:

• Review of epidemiological data and clinical studies linking Type-2 diabetes to cancer incidence.
• Analysis of synergistic effects of T2D with risk factors such as obesity, smoking, and infections.
• Assessment of cancer mortality patterns in T2D patient cohorts.

Main Results:

• Type-2 diabetes demonstrates a causal link to colorectal, pancreatic, liver, breast, kidney, and other cancers.
• Combined risk factors with T2D lead to earlier cancer diagnosis and increased cumulative risk.
• Malignancies represent a major cause of death in patients with Type-2 diabetes.

Conclusions:

• Type-2 diabetes is strongly associated with an increased risk and incidence of multiple cancers.
• Proactive cancer screening, potentially at younger ages, is crucial for T2D patients.
• Public health strategies should emphasize cancer prevention and early detection in diabetic populations.